默克尔细胞癌与免疫抑制、紫外线辐射及多瘤病毒的归因分析
该研究整合美国种群登记和病例系列数据,估算默克尔细胞癌(MCC)可归因于免疫抑制、环境紫外线(UVR)和默克尔细胞多瘤病毒(MCPyV)的比例。结果显示65.1%的MCC可归因于UVR,63.8%可归因于MCPyV,而免疫抑制条件贡献较小。
要点
- 大多数MCC可归因于环境UVR暴露或MCPyV感染。
- 免疫抑制条件(HIV、移植、CLL)仅占MCC的极小部分。
- 降低MCC发病率应重点限制UVR暴露。
核心结论
- 美国大多数MCC病例可归因于环境UVR暴露或MCPyV,免疫抑制条件贡献较小。
- 降低MCC发病率应关注限制UVR暴露。
研究设计与样本
- 流行病学评估结合种群登记和病例系列数据,纳入2001年1月至2019年12月诊断的MCC病例。
- 通过种群癌症登记及HIV和移植登记链接识别HIV感染者、实体器官移植受者和CLL患者的MCC。
- 基于云调整的每日环境UVR辐照度与诊断时居住县的癌症登记数据合并。
- 通过meta分析合并报告美国MCC标本中MCPyV患病率的研究。
主要发现
- 共诊断38 020例MCC,其中女性14 325例(38%),西班牙裔1 586例(4%),非西班牙裔黑人561例(1%),非西班牙裔白人35 171例(93%)。
- 与一般美国人群相比,MCC发病率在HIV感染者(SIR 2.78)、器官移植受者(SIR 13.1)和CLL患者(SIR 5.75)中升高。
- 仅0.2%(95%CI 0.1%-0.3%)的MCC归因于HIV,1.5%(95%CI 1.4%-1.7%)归因于实体器官移植,0.8%(95%CI 0.5%-1.3%)归因于CLL。
- 与非西班牙裔白人相比,少数种族和族裔群体在较低和较高环境UVR暴露水平下MCC发病率均升高(头颈部MCC的发病率比分别为4.05和4.91)。
- 总体65.1%(95%CI 63.6%-66.7%)的MCC归因于UVR;基于19个病例系列的meta分析,63.8%(95%CI 54.5%-70.9%)的MCC归因于MCPyV。
关键数值与推荐
- MCC归因于HIV的比例为0.2%(95%CI 0.1%-0.3%)。
- MCC归因于实体器官移植的比例为1.5%(95%CI 1.4%-1.7%)。
- MCC归因于CLL的比例为0.8%(95%CI 0.5%-1.3%)。
- MCC归因于UVR的比例为65.1%(95%CI 63.6%-66.7%)。
- MCC归因于MCPyV的比例为63.8%(95%CI 54.5%-70.9%)。
临床怎么用
- 临床应重视UVR暴露作为MCC主要可干预风险因素,建议患者防晒。
- 对免疫抑制患者(HIV、移植、CLL)应关注MCC风险升高,但群体归因比例小。
- MCPyV和UVR是MCC的主要归因因素,可用于患者教育和预防策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Merkel cell carcinoma (MCC) is a rare but aggressive skin cancer. Quantifying the contribution of major potentially modifiable risk factors to the burden of MCC may inform prevention efforts. OBJECTIVE: To estimate the population attributable fraction of MCC cases in the US that were attributable to major immunosuppressing conditions (eg, HIV, solid organ transplant, chronic lymphocytic leukemia [CLL]), ambient UV radiation [UVR] exposure, and Merkel cell polyomavirus [MCPyV]). DESIGN, SETTING, AND PARTICIPANTS: This epidemiological assessment combined data from population-based registries and case series and included cases of MCC that were diagnosed from January 2001 to December 2019 diagnosed in people with HIV, solid organ transplant recipients, and patients with CLL who were identified through population-based cancer registries and linkages with HIV and transplant registries. UVR-based on cloud-adjusted daily ambient UVR irradiance was merged with cancer registry data on the county of residence at diagnosis. Studies reporting the prevalence of MCPyV in MCC specimens collected in the US were combined via a meta-analysis. EXPOSURES: HIV, solid organ transplant, CLL, UVR, and MCPyV. MAIN OUTCOMES AND MEASURES: Population attributable fraction of MCC cases attributable to major risk factors. RESULTS: A total of 38 020 MCCs were diagnosed in the US among xx patients (14 325 [38%] female individuals; 1586 [4%] Hispanic, 561 [1%] non-Hispanic Black, and 35 171 [93%] non-Hispanic White individuals). Compared with the general US population, MCC incidence was elevated among people with HIV (standardized incidence ratio [SIR], 2.78), organ transplant recipients (SIR, 13.1), and patients with CLL (SIR, 5.75). Due to the rarity of these conditions, only 0.2% (95% CI, 0.1%-0.3%) of MCC cases were attributable to HIV, 1.5% (95% CI, 1.4%-1.7%) to solid organ transplant, and 0.8% (95% CI, 0.5%-1.3%) to CLL. Compared with individuals of racial and ethnic minority groups, MCC incidence was elevated among non-Hispanic White individuals at lower and higher ambient UVR exposure levels (incidence rate ratios: 4.05 and 4.91, respectively, for MCC on the head and neck). Overall, 65.1% (95% CI, 63.6%-66.7%) of MCCs were attributable to UVR. Based on a meta-analysis of 19 case series, 63.8% (95% CI, 54.5%-70.9%) of MCCs were attributable to MCPyV. Studies were identified from a MEDLINE search performed on October 12, 2023. CONCLUSIONS AND RELEVANCE: The results of this study suggest that most MCC cases in the US were attributable to ambient UVR exposure or MCPyV, with a small fraction due to immunosuppressive conditions. Efforts to lower MCC incidence could focus on limiting UVR exposure.
引用
- Tribble JT, Pfeiffer RM, Brownell I, et al. Merkel Cell Carcinoma and Immunosuppression, UV Radiation, and Merkel Cell Polyomavirus. JAMA Dermatol. 2025. PMID: 39602110. doi:10.1001/jamadermatol.2024.4607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。